Lesley Fallowfield

47.9k total citations · 10 hit papers
351 papers, 24.4k citations indexed

About

Lesley Fallowfield is a scholar working on Oncology, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lesley Fallowfield has authored 351 papers receiving a total of 24.4k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Oncology, 81 papers in General Health Professions and 71 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lesley Fallowfield's work include Cancer survivorship and care (74 papers), Patient-Provider Communication in Healthcare (71 papers) and Breast Cancer Treatment Studies (51 papers). Lesley Fallowfield is often cited by papers focused on Cancer survivorship and care (74 papers), Patient-Provider Communication in Healthcare (71 papers) and Breast Cancer Treatment Studies (51 papers). Lesley Fallowfield collaborates with scholars based in United Kingdom, United States and Switzerland. Lesley Fallowfield's co-authors include Valerie Jenkins, Angela Hall, J Saul, Michael Baum, David Cella, Sarah Ford, Susan Catt, Shôn Lewis, Anne Fleissig and Vernon T. Farewell and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lesley Fallowfield

341 papers receiving 23.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

2006 1.2k citations Lesley Fallowfield et al. profile →
Ovarian cancer

2016 842 citations Lesley Fallowfield et al. profile →
Communicating sad, bad, and difficult news in medicine

2004 710 citations Lesley Fallowfield, Valerie Jenkins profile →
Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial

2002 642 citations Lesley Fallowfield, Valerie Jenkins et al. profile →
Information needs of patients with cancer: results from a large study in UK cancer centres

2001 621 citations Valerie Jenkins, Lesley Fallowfield et al. British Journal of Cancer profile →
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.

1990 619 citations Lesley Fallowfield, Michael Baum et al. profile →
Psychiatric morbidity and its recognition by doctors in patients with cancer

2001 557 citations Lesley Fallowfield, Valerie Jenkins et al. British Journal of Cancer profile →
Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction

2000 519 citations Lesley Fallowfield et al. profile →
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

2016 446 citations Lesley Fallowfield, Harold J. Burstein et al. Journal of Clinical Oncology profile →
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

2022 227 citations Lesley Fallowfield et al. profile →

Peers

Countries citing papers authored by Lesley Fallowfield

Since Specialization

Citations

This map shows the geographic impact of Lesley Fallowfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Fallowfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Fallowfield more than expected).

Fields of papers citing papers by Lesley Fallowfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Fallowfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Fallowfield. The network helps show where Lesley Fallowfield may publish in the future.

Co-authorship network of co-authors of Lesley Fallowfield

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Fallowfield. A scholar is included among the top collaborators of Lesley Fallowfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Fallowfield. Lesley Fallowfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Best practices for communication of prognosis and end-of-life discussions with patients with advanced breast cancer: A report from the advanced breast cancer global alliance 2025 ·The Breast ·Lesley Fallowfield, Belinda E. Kiely, Luzia Travado, (unknown), (unknown), Fátima Cardoso	0
2	Qualitative Findings From a Survey Measuring Informational Needs and Quality of Life of Women Living With Metastatic Breast Cancer 2025 ·Psycho-Oncology ·(unknown), Lesley Fallowfield, Stephanie Russ, Valerie Jenkins	0
3	Incidence and management of diarrhoea associated with abemaciclib and endocrine therapy for hormone-receptor positive, HER2-negative metastatic breast cancer: the UK patients’ experiences 2025 ·Supportive Care in Cancer ·Helena Harder, (unknown), Lesley Fallowfield, (unknown), Valerie Shilling	1
4	Exploring the real-world experience of abemaciclib treatment for HR +, HER2 − metastatic breast cancer—a qualitative analysis of the IMPACTOR study 2025 ·Supportive Care in Cancer ·(unknown), Helena Harder, Lesley Fallowfield, Valerie Shilling	1
5	Improving patient understanding of GEP test results (IMPARTER4): an RCT 2025 ·PubMed ·Lesley Fallowfield, Ivonne Solis‐Trapala, (unknown), Lucy Matthews, (unknown), Valerie Jenkins	0
6	Targeted Therapies, Sequencing Strategies, and Beyond in Metastatic Hormone Receptor–Positive Breast Cancer: ASCO Guideline Clinical Insights 2024 ·JCO Oncology Practice ·Igor Makhlin, Lesley Fallowfield, N. Lynn Henry, Harold J. Burstein, Mark R. Somerfield, Angela DeMichele	8
7	A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer 2024 ·Current Oncology ·Sharon F. McGee, Mark Clemons, Gregory R. Pond, Jean-Michel Caudrelier, (unknown), (unknown), Terry L. Ng, Arif Awan, Sandeep Sehdev, John Hilton, (unknown), Lesley Fallowfield, (unknown), Orit Freedman, Lisa Vandermeer, Brian Hutton, Jean‐Marc Bourque	2
8	Removal or ablation of asymptomatic lung metastases should be reconsidered 2023 ·BMJ ·Fergus Macbeth, Lesley Fallowfield, Elizabeth Treasure, Irfan Ahmad, Yan Zheng, Tom Treasure	1
9	A structured Review of Quality of Life in Advanced and High-Risk Cutaneous Squamous Cell Carcinoma Shows the Need for More Studies and Better Measures 2021 ·SHILAP Revista de lepidopterología ·(unknown), Valerie Shilling, Valerie Jenkins, Lesley Fallowfield	7
10	An online review of informational sources for advanced or high-risk cutaneous squamous cell carcinoma 2021 ·Supportive Care in Cancer ·(unknown), Valerie Shilling, Lesley Fallowfield	1
11	A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer 2020 ·Breast Cancer Research and Treatment ·(unknown), Valerie Shilling, Valerie Jenkins, Lesley Fallowfield	11
12	Development and validation of the caregiver roles and responsibilities scale in cancer caregivers 2019 ·Quality of Life Research ·Valerie Shilling, (unknown), Valerie Jenkins, David Cella, Lesley Fallowfield	9
13	Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for clinicians 2019 ·Breast Cancer Research and Treatment ·Lesley Fallowfield, Ivonne Solis‐Trapala, (unknown), Susan Catt, (unknown), Valerie Jenkins	10
14	RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Anthony Howell, Linda Ashcroft, Lesley Fallowfield, Diana Eccles, Rosalind A. Eeles, Ann Ward, Adam R. Brentnall, Mitch Dowsett, Jack Cuzick, (unknown), Caroline Boggis, (unknown), Jamie C. Sergeant, Judith E. Adams, D. Gareth Evans	4
15	What Oncologists Believe They Said and What Patients Believe They Heard: An Analysis of Phase I Trial Discussions 2010 ·Journal of Clinical Oncology ·Valerie Jenkins, Ivonne Solis‐Trapala, C. Langridge, Susan Catt, Denis Talbot, Lesley Fallowfield	105
16	Epoetin alfa improves quality of life in patients with cancer 2004 ·Cancer ·Michael Jones, Brad Schenkel, (unknown), Lesley Fallowfield	69
17	Quality of life assessments may help some patients (Letter) 1998 ·UCL Discovery (University College London) ·Clare Saunders, (unknown), Lesley Fallowfield	1
18	Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life 1993 ·British Journal of Cancer ·(unknown), H.J. Dobbs, SR Ebbs, Lesley Fallowfield, T Bates, Michael Baum	36
19	The ideal consultation. 1992 ·Lesley Fallowfield	43
20	Challenging Cancer. From Chaos to Control 1992 ·Journal of the Royal Society of Medicine ·Lesley Fallowfield	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact